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Abstract 
Background: Vanillin is an industrially valuable molecule that can be produced from simple carbon sources in engi-
neered microorganisms such as Saccharomyces cerevisiae and Escherichia coli. In E. coli, de novo production of vanillin 
was demonstrated previously as a proof of concept. In this study, a series of data-driven experiments were performed 
in order to better understand limitations associated with biosynthesis of vanillate, which is the immediate precursor 
to vanillin.
Results: Time-course experiments monitoring production of heterologous metabolites in the E. coli de novo vanillin 
pathway revealed a bottleneck in conversion of protocatechuate to vanillate. Perturbations in central metabolism 
intended to increase flux into the heterologous pathway increased average vanillate titers from 132 to 205 mg/L, but 
protocatechuate remained the dominant heterologous product on a molar basis. SDS-PAGE, in vitro activity measure-
ments, and l-methionine supplementation experiments suggested that the decline in conversion rate was influenced 
more by limited availability of the co-substrate S-adenosyl-l-methionine (AdoMet or SAM) than by loss of activity of 
the heterologous O-methyltransferase. The combination of metJ deletion and overexpression of feedback-resistant 
variants of metA and cysE, which encode enzymes involved in SAM biosynthesis, increased average de novo vanillate 
titers by an additional 33 % (from 205 to 272 mg/L). An orthogonal strategy intended to improve SAM regeneration 
through overexpression of native mtn and luxS genes resulted in a 25 % increase in average de novo vanillate titers 
(from 205 to 256 mg/L). Vanillate production improved further upon supplementation with methionine (as high as 
419 ± 58 mg/L), suggesting potential for additional enhancement by increasing SAM availability.
Conclusions: Results from this study demonstrate context dependency of engineered pathways and highlight the 
limited methylation capacity of E. coli. Unlike in previous efforts to improve SAM or methionine biosynthesis, we pur-
sued two orthogonal strategies that are each aimed at deregulating multiple reactions. Our results increase the work-
ing knowledge of SAM biosynthesis engineering and provide a framework for improving titers of metabolic products 
dependent upon methylation reactions.
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Background
Few biological molecules are as widely savored by 
humans as vanillin. Vanillin is the dominant flavor con-
stituent in natural vanilla extract and the most heavily 
used food additive for flavoring annually by volume [1, 
2]. Vanillin also has a variety of industrial uses, includ-
ing as an intermediate in the chemical and pharmaceu-
tical industries for production of herbicides, antifoaming 
agents, and drugs [3]. Biosynthesis of vanillin occurs 
naturally in the tropical vanilla orchid (Vanilla planifo-
lia) and in trace amounts in other plants [3]. In V. plani-
folia, vanillin forms inside inedible pods or beans from 
which it must be extracted. Vanilla beans are harvested 
roughly 6–8 months after pollination and are subject to 
a curing process that can take more than 6  months to 
complete [3]. Inefficiencies stemming from V. planifolia 
cultivation are manifested in the high price of natural 
vanilla extract, which is estimated to be between $1000 
and $4000 per kilogram [3]. Given that, researchers have 
sought to develop biosynthetic routes to vanillin in other 
host organisms. Ideally, these heterologous hosts could 
produce vanillin from glucose as a sole carbon source (de 
novo biosynthesis) given the abundance and affordability 
of glucose relative to other potential substrates [4].
De novo vanillin biosynthesis has been demonstrated 
in two of the industrial biotechnology workhorse organ-
isms: S. cerevisiae (baker’s yeast) [4] and Escherichia coli 
[5]. De novo production of vanillin in a heterologous 
host organism was first reported in both S. cerevisiae and 
Schizosaccharomyces pombe in 2009 [4]. The engineered 
metabolic pathway in yeast featured three heterologous 
enzymes: a dehydroshikimate dehydratase, an O-methyl-
transferase, and a carboxylic acid reductase. This pathway 
is similar to the E. coli pathway engineered by Frost and 
co-workers in 1998 [6]. The E. coli pathway was designed 
to produce vanillate in  vivo using a heterologous dehy-
droshikimate dehydratase and O-methyltransferase. Sub-
sequent reduction of purified vanillate into vanillin was 
catalyzed by a carboxylic acid reductase in  vitro. The 
presumed rationale for the original two-stage vanillin 
pathway was that E. coli exhibits a high degree of alde-
hyde reductase activity catalyzed by numerous unknown 
endogenous enzymes, which would result in formation of 
vanillyl alcohol in  vivo instead of vanillin. The problem 
of endogenous aromatic aldehyde reduction was recently 
addressed [5, 7], leading to a strain capable of accumulat-
ing aldehydes including vanillin (E. coli RARE, Addgene 
Catalog #61440). At that time, the de novo vanillin 
pathway was constructed in E. coli as one of two dem-
onstrated and industrially relevant applications for the 
RARE strain.
When de novo biosynthesis was first reported in yeast 
and in E. coli, vanillin titers achieved were similarly low 
under comparable flask-scale conditions (65  mg/L in S. 
pombe supplied with yeast extract-based media [4] ver-
sus 119 or 56  mg/L in E. coli supplied with glucose in 
LB or M9 minimal media [5], respectively). Production 
of vanillin or vanillin-β-d-glucoside in yeast has since 
been enhanced [8, 9] and even commercialized by the 
company Evolva [10]. Numerous differences between 
eukaryotic yeast and prokaryotic E. coli led us to suspect 
that similar de novo pathways might suffer from differ-
ent host-dependent limitations. Metabolic engineering 
reviews that discuss host selection not only compare nat-
ural differences in metabolic fluxes and regulation across 
model organisms such as yeast and E. coli [11] but also 
highlight dissimilarities in these respects among different 
species of yeast [12] and even among different strains of 
E. coli [13].
In this report, we describe a series of metabolic engi-
neering experiments used to improve the production of 
vanillate from glucose as a sole carbon source using E. 
coli. We initially focus on increasing flux into the engi-
neered pathway by perturbing pool sizes of precur-
sor molecules and observing the effect on heterologous 
metabolite titers as a function of time in order to identify 
pathway bottlenecks downstream. To simplify our analy-
sis, we exclude the confounding presence of aldehyde 
products, which exert negative effects on titer by inhibit-
ing cell growth [5, 14]. We achieve this by omitting the 
carboxylic acid reductase CarNi from the pathway, which 
results in vanillate as the intended final product rather 
than vanillin (Fig. 1a).
Our findings indicate that limited availability of 
S-adenosylmethionine (SAM) represents a major hurdle 
to the improvement of vanillate titers from glucose as a 
sole carbon source in E. coli. To improve vanillate titers, 
we deregulate reactions in SAM biosynthesis and regen-
eration using two orthogonal strategies. Improvements 
in vanillate formation as a function of increased SAM 
availability have impact beyond the vanillin pathway 
given that SAM-dependent methyltransferases consti-
tute a broad class of enzymes with potential for engineer-
ing numerous metabolic products [15, 16]. Our results 
increase the working knowledge of SAM biosynthesis 
engineering and provide a framework for improving 
titers of metabolic products dependent upon methylation 
reactions.
Results
Time‑course experiments monitoring heterologous 
metabolites reveal limitation in conversion 
of protocatechuate to vanillate
As a starting point for understanding pathway limita-
tions, we sought to increase carbon flux entering the 
heterologous portion of the vanillate pathway (Fig.  1a). 
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We hypothesized that increasing flux would facilitate the 
identification of pathway bottlenecks based on changes in 
titer (units of mg/L) and specific yields [units of g/gDCW 
(grams of dry cell weight)] of intermediate metabolites. 
In our previous demonstration of de novo vanillin bio-
synthesis, titers of all measured heterologous metabolites 
(protocatechuate, vanillate, protocatechualdehyde, and 
vanillin) were low, each less than 60  mg/L [5]. Initially, 
we sought to achieve increased heterologous metabolite 
titers by targeting endogenous precursor biosynthesis 
genes for overexpression given that the first heterologous 
enzyme (AsbFBt) is reported to efficiently catalyze con-
version of endogenous 3-dehydroshikimate into proto-
catechuate [17].
The heterologous vanillate pathway branches from 
endogenous aromatic amino acid biosynthesis, and 
efforts to improve aromatic amino acid biosynthesis in 
E. coli have been well-documented [18–20]. In our initial 
demonstration of vanillin synthesis, we harnessed one of 
these strategies by expressing a feedback-resistant variant 
of the enzyme that catalyzes the first committed step to 
aromatic amino acid biosynthesis (aroG*) [5]. Previous 
studies demonstrated two other strategies that were suc-
cessfully used to increase titers of aromatic products, in 
these cases by increasing availability of two key aromatic 
precursor metabolites: phosphoenolpyruvate (PEP) from 
glycolysis and erythrose-4-phosphate (E4P) from the pen-
tose phosphate pathway. PEP and E4P condense to form 
DAHP during the first committed step towards aromatic 
amino acid biosynthesis (Fig. 1a) [18–20]. One reported 
strategy to increase their availability is deletion of the 
phosphotransferase system (PTS), which is the primary 
means for glucose import and consumes 1 mole of PEP 
per mole of glucose. Growth of a PTS− strain on glucose 
Fig. 1 Conversion of protocatechuate to vanillate limits engineered de novo vanillin biosynthesis in E. coli. a Metabolic pathway diagram depict-
ing engineered route from glucose to vanillin. Genes corresponding to enzymes labeled in red are overexpressed in this study. Enzymes written 
without subscripts are native to E. coli. Dashed blue lines indicate the heterologous portion of the pathway. The gene corresponding to CarNi (shown 
in gray) is not overexpressed throughout this study to avoid confounding presence of aldehydes during pathway troubleshooting. Thus, only solid 
blue arrows represent heterologous reaction steps pertaining to this study, where vanillate is the desired end product. Maximum theoretical yields 
of vanillin and vanillate using this pathway are 0.395 and 0.414 mol/mol_glucose, respectively. b Time-course experiment in which the PTS− glu+ 
RAREʹ host strain was transformed to express aroG*, asbFBt, and OMTHs or ppsA and tktA in addition to the other genes. Titers of heterologous metab-
olites protocatechuate and vanillate were measured every 12 h by HPLC and reveal bottleneck in conversion of protocatechuate to vanillate. Genes 
overexpressed in each experiment are labeled in red. Titers of protocatechuate increase by roughly 50 % when ppsA and tktA are overexpressed, 
suggesting flux into the heterologous pathway increased. However, vanillate titers do not improve, motivating subsequent focus on conversion of 
protocatechuate to vanillate
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as a sole carbon source can be made viable by upregulat-
ing the gene encoding galactose permease (galP), which 
allows glucose entry independent of PEP consumption 
(PTS− glu+). A second documented strategy to increase 
availability of PEP and E4P is to overexpress the genes 
encoding PEP synthase (ppsA) and transketolase (tktA) 
[18–20]. PEP synthase catalyzes the conversion of PEP 
into pyruvate, and transketolase catalyzes the reversible 
formation of E4P and xylulose 5-phosphate from fructose 
6-phosphate and glyceraldehyde 3-phosphate.
To test these strategies, we engineered a PTS− glu+ 
variant of the RARE strain (PTS− glu+ RAREʹ), where 
the “RARE prime” designation indicates that this strain 
contains intact versions of two genes (dkgB and yeaE) 
that were targeted for deletion in the original RARE 
strain. Previous work found that these two genes did not 
substantially contribute to aldehyde reductase activity 
given their low native expression [5]. When the PTS− 
glu+ RAREʹ host overexpressed the aroG*, asbFBt, and 
OMTHs genes, 132 ± 14 mg/L of vanillate was produced 
72 h after induction (Fig. 1b). When the same host was 
used to express the ppsA and tktA genes in addition to 
the previously mentioned pathway genes, vanillate titers 
slightly decreased but cumulative titers of heterologous 
metabolites increased. Specifically, protocatechuate titer 
increased from 200 to 300  mg/L in strains expressing 
the ppsA and tktA genes. In addition, the specific yield 
of protocatechuate noticeably increased around 24  h 
after pathway induction when ppsA and tktA were over-
expressed (Additional file  1: Figure S1). In both experi-
ments, protocatechuate was the dominant heterologous 
metabolite formed on a molar basis, and this suggested 
that the reaction catalyzed by the O-methyltransferase 
was limiting. It is possible that the decrease in vanillate 
titers resulted either from decreased OMTHs expression 
as two additional genes were being expressed, or from 
the decreased rate of biomass formation during expres-
sion of the two additional genes (Additional file 1: Figure 
S1), or from both contributions.
Although the gene encoding OMTHs was codon-
optimized for expression in E. coli, we next wondered 
whether OMTHs may be expressing poorly or whether it 
may have low activity in E. coli. SDS-PAGE results sug-
gested that OMTHs expresses well (Fig.  2a). In addition, 
cultures expressing the pathway were sampled for in vitro 
specific OMTHs activity. Activity measurements revealed 
that, while OMTHs activity decreases to 34 % of initially 
measured activity, the enzyme is still active 48  h after 
induction (Fig. 2b).
Supplementation of methionine and homocysteine 
improve vanillate titers, strongly suggesting 
that availability of the co‑substrate S‑adenosylmethionine 
(SAM) limits conversion of protocatechuate to vanillate
Given that OMTHs appeared to be expressed and active 
in cells at times when conversion of protocatechuate to 
vanillate was not occurring, we next considered that co-
substrate availability may be limiting (Fig.  3a). The co-
substrate SAM fulfills a variety of cellular roles, such as 
serving as the primary methyl donor for all cellular meth-
ylations, which compete directly with the engineered 
vanillin pathway. Methionine is endogenously converted 
Fig. 2 Expression and activity data suggests principal limitation is not heterologous O-methyltransferase. a SDS-PAGE gel suggesting robust OMTHs 
expression in soluble fractions of cells sampled from flask cultures. b In vitro specific activity measurements normalized to activity at 12 h time 
point. Activity data indicates that OMTHs activity declines from 12 to 48 h. However, notable activity even at 48 h strongly suggests that loss of 
OMTHs activity is not responsible for observed reduction in rate of vanillate formation
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to SAM by methionine adenosyltransferase (otherwise 
known as SAM synthetase) encoded by metK. Although 
exogenously supplied SAM does not enter E. coli, exog-
enously supplied methionine does enter cells and is 
known to indirectly perturb intracellular SAM availabil-
ity in E. coli [6] and in yeast [21]. Importantly, in the sole 
previously reported effort to produce vanillate using E. 
coli, it was observed that methionine supplementation 
improved titers [6].
We monitored vanillate titers in cultures with and 
without supplementation of 10 mM l-methionine at peak 
vanillate productivity (24  h after induction) (Fig.  3b). 
Although methionine supplementation did not result in 
significant changes in vanillate titer immediately, final 
vanillate titer increased twofold 72  h after induction. 
In addition, vanillate synthesis occurred at a relatively 
constant rate until the final sampling time of 72 h upon 
methionine supplementation. This result suggests that 
potential depletion of SAM and methionine pools later in 
the culture may be responsible for limiting conversion of 
protocatechuate to vanillate.
To better understand the contributions of methionine 
biosynthesis to the vanillate pathway, a second supple-
mentation experiment was performed, this time with the 
direct precursor to methionine, l-homocysteine (Fig. 3a). 
The methylation of homocysteine to form methionine 
is reported to be problematic under oxidative condi-
tions due to the inactivation of catalytic residues in the 
cobalamin-independent methionine synthase (MetE) 
[22–25]. As before, cultures at peak vanillate productiv-
ity (24 h) were supplemented with and without l-homo-
cysteine. Because l-homocysteine is reported to be toxic 
Fig. 3 Supplementation experiments indicate limiting S-adenosylmethionine (SAM) availability and demonstrate SAM biosynthesis bottleneck 
upstream of homocysteine. a Metabolic pathway diagram illustrating co-substrate requirement for reaction catalyzed by O-methyltransferase. SAM 
is generated from methionine, which in turn is generated from homocysteine. b Vanillate titers resulting from the presence or absence of 10 mM 
methionine supplementation to cultures 24 h after induction. Cultures receiving methionine produced nearly twofold higher vanillate titers. c Vanil-
late titers resulting from the presence or absence of 2.5 mM homocysteine supplementation to cultures 24 h after induction. Lower concentrations of 
homocysteine were used relative to methionine given the potential for homocysteine toxicity. Once again, cultures receiving supplement produced 
nearly twofold higher vanillate titers. d Vanillate specific yields resulting from homocysteine supplementation experiment. Higher specific yield upon 
homocysteine supplementation demonstrates that increased vanillate production is due to greater output per cell and not because of additional 
biomass. These pathway experiments used the PTS− glu+ RAREʹ host and overexpression of aroG*,asbFBt, OMTHs, ppsA, and tktA
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for E. coli [26, 27], we added 2.5 mM rather than 10 mM. 
Once again, supplemented cultures displayed an increase 
in vanillate titer (up to 200  mg/L) and an increase in 
duration of vanillate production consistent with what 
was observed for l-methionine addition (Fig.  3c). The 
average rate of vanillate synthesis doubled from 1.3 to 
2.6 mg/L h. Importantly, vanillate specific yields showed 
that homocysteine supplementation led to higher specific 
production of vanillate rather than higher cell density 
(Fig.  3d). These results collectively suggested that reac-
tions upstream of homocysteine synthesis in the methio-
nine biosynthesis pathway need to be targeted to achieve 
increases in vanillate production from glucose as a sole 
carbon source.
Unlike aromatic amino acid biosynthesis, methio-
nine biosynthesis in E. coli and other bacteria is not well 
understood and is regulated at multiple transcriptional as 
well as post-transcriptional levels (Fig. 4a). In fact, until 
recently, methionine was the only essential amino acid 
that was not commercially produced using fermentative 
processes [28, 29]. The protein encoded by metJ is the pri-
mary transcriptional regulator of several genes involved 
in methionine biosynthesis [30–32]. Methionine titers 
of 910  mg/L were previously achieved using an E. coli 
strain that was constructed by mutagenesis with nitro-
soguanidine along with selection based on resistance to 
methionine analogs. This strain was observed to have a 
mutation in metJ that decreased repression of methio-
nine biosynthesis [33]. However, genome sequencing was 
not performed and it is unlikely that metJ was the only 
gene containing a mutation. In addition to regulation by 
metJ, MetA (homoserine succinyltransferase) catalyzes 
the first committed step in methionine biosynthesis and 
is reported to be inhibited by both methionine and SAM 
[34]. l-cysteine is also a precursor to methionine. CysE 
(l-serine O-acetyltransferase) catalyzes the first step of 
cysteine biosynthesis and is reported to display signifi-
cant inhibition by cysteine [35]. Fortunately, variants of 
MetA and CysE that have been engineered to display 
desensitization to feedback inhibition (MetA* and CysE*) 
Fig. 4 Effect of metJ deletion on protocatechuate and vanillate titers (a) in different host strains and (b) in the presence of amino acid supplemen-
tation. For these experiments, the following genes were overexpressed: aroG*,asbFBt, OMTHs, ppsA, and tktA. For the amino acid supplementation 
experiment (c), 10 mM of amino acid was added at induction. d Effect of overexpressing feedback-desensitized variants of metA and cysE along with 
aroG*,asbFBt, OMTHs, ppsA, and tktA in the RARE ∆metJ host. The control represents co-transformation with an empty pCOLADuet-1 plasmid
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have been reported [34, 35]. The combination of metA* 
expression, metJ deletion, and other modifications have 
previously led to a strain that accumulated 240 mg/L of 
methionine [34].
Deregulation of SAM biosynthesis through deletion 
of metJ and expression of metA* and cysE* improves 
vanillate titers
We hypothesized that vanillate titers might increase 
if methionine biosynthesis were modified by (i) delet-
ing metJ; and (ii) expressing metA* and cysE* (Fig.  4a). 
Given our observation of slower growth in the PTS− glu+ 
RAREʹ strain relative to the RARE strain, we decided to 
delete metJ in both strains and compare performance. 
Upon overexpression of aroG*, asbF, OMT, ppsA, and 
tktA, the RARE ∆metJ host resulted in higher titers of 
protocatechuate and vanillate than the PTS− glu+ RAREʹ 
∆metJ host (Fig.  4b). However, protocatechuate titers 
remained higher than vanillate titers in both cases. As 
previously noted, metJ is only one of many simultane-
ous modes of methionine biosynthesis regulation. Given 
feedback-resistance at the entrance to the pathway, 
one could envision the metJ deletion strain performing 
slightly worse because of increased expression of down-
stream genes with minimal flux entering the pathway. 
Given that the RARE ∆metJ host performed better than 
the PTS− glu+ RAREʹ ∆metJ host, we decided to continue 
with RARE ∆metJ for remaining experiments.
To further understand the limitations in methionine 
biosynthesis, we next supplemented the RARE ∆metJ 
host harboring the pathway with one of three amino 
acids: l-methionine, l-cysteine, and l-aspartate. Because 
cysteine and aspartate are precursors to methionine 
(Fig.  4a), our goal was to investigate whether reaction 
steps downstream of their biosynthesis were problem-
atic. In this case, we added 10  mM of each amino acid 
at the time of induction (0 h) to see whether the time of 
supplementation would affect pathway kinetics. In this 
experiment, we also included the RARE host (with metJ 
intact) expressing the pathway in order to better under-
stand the potential effect of metJ deletion. Performance 
of the RARE and RARE ∆metJ hosts supplemented with 
methionine was similar, with roughly 280 mg/L vanillate 
produced in just 24 h (Fig. 4c). Little additional vanillate 
formed after the first 24  h, suggesting that methionine 
supplementation at induction might be more effective 
than supplementation at 24 h. The decrease in the rate of 
vanillate formation suggested that all of the methionine 
added initially may have been depleted within 24 h. Addi-
tion of l-cysteine or l-aspartate did not improve vanillate 
titers, which supported the notion of next focusing on the 
reactions catalyzed by MetA and CysE. Interestingly, bio-
mass formation occurred more rapidly than usual during 
l-aspartate supplementation, suggesting that uptake 
of this amino acid occurred readily but was diverted to 
other cellular purposes besides methionine biosynthesis 
(Additional file 1: Figure S2). On the other hand, addition 
of 10  mM l-cysteine significantly decreased titers and 
biomass formation. Cysteine has been shown to inhibit 
the growth of several E. coli strains by inhibiting threo-
nine deaminase and therefore isoleucine synthesis [36].
We next explored whether expression of the metA* 
and cysE* genes would improve conversion of vanillate to 
protocatechuate without the addition of l-methionine to 
the culture medium (Fig. 4d). In the cases in which metA* 
and cysE* were overexpressed, average vanillate titer 
was observed to exceed average protocatechuate titer 
at all time points sampled. Expression of metA*−cysE* 
increased final vanillate titers by 33  % (from 205  ±  16 
to 272 ± 35 mg/L). To gain insight into potential upper 
bounds of vanillate titer obtainable by increasing SAM 
availability, we supplemented cultures expressing 
metA*−cysE* with 10 mM methionine at both induction 
and at 24 h after induction (Additional file 1: Figure S3). 
In this case, vanillate titers continued to exceed proto-
catechuate titers at all time points sampled. Addition of 
methionine at induction led to 341 ± 25 mg/L of vanil-
late produced in the first 24 h. This suggested that further 
increased SAM availability within the first 24  h could 
still improve vanillate production. Although the addi-
tion of an extra 10 mM methionine (20 mM methionine 
total) at 24 h after induction resulted in a final vanillate 
titer of 419 ± 58 mg/L at 72 h after induction, protocat-
echuate titers remained above 100 mg/L. Thus, a strategy 
of additional exogenous methionine supplementation is 
insufficient to address the limitation of protocatechuate 
conversion, particularly once cultures have achieved late 
exponential or stationary phase. Given continued obser-
vations of a decreasing rate of vanillate formation after 
24 h, we also investigated potential loss of the ampicillin-
resistant plasmid harboring OMT (pET-AsbF-OMT). 
Based on the similar number of colonies appearing on 
plates taken at the same time points (Additional file  1: 
Figure S4), we could rule out plasmid loss as an explana-
tion for the limited conversion observed.
Orthogonal strategy of deregulating SAM regeneration 
through overexpression of mtn and luxS also achieves 
improvement in vanillate titers
To our knowledge, no previous study has sought to 
increase SAM availability by targeting genes downstream 
of SAM utilization, in what is known as the activated 
methyl cycle. S-adenosyl-l-homocysteine (SAH) is a co-
product of the reaction along with vanillate, and SAH 
is a potent inhibitor of SAM-dependent methyltrans-
ferases [37, 38] (Fig. 5a). Homocysteine supplementation 
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Fig. 5 Orthogonal strategy of increasing S-adenosylhomocysteine (SAH) recycling through overexpression of mtn and luxS also improves vanillate 
titer. a The activated methyl cycle in E. coli (in black and red), along with an alternative SAH recycling route featuring a heterologous SAH hydrolase 
(sahHSc, in blue). Native genes targeted for overexpression (mtn and luxS) are shown in red. b Effect of expressing sahHSc with aroG*,asbFBt, OMTHs, 
ppsA, and tktA in the RARE ∆metJ host on protocatechuate and vanillate titers. c Effect of overexpressing mtn and luxS with aroG*,asbFBt, OMTHs, 
ppsA, and tktA in the RARE ∆metJ host on protocatechuate and vanillate titers. d Effect of 10 mM methionine supplementation at induction on pro-
tocatechuate and vanillate titers using strains expressing sahHSc. e Effect of 10 mM methionine supplementation at induction on protocatechuate 
and vanillate titers using strains overexpressing mtn and luxS
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results presented earlier suggested that recycling of SAH 
back to homocysteine does not occur at a rate sufficient 
to maintain SAM availability. One of the two reactions 
required to recycle SAH is catalyzed by Mtn and con-
verts SAH to S-ribosyl-l-homocysteine (SRH). The sub-
sequent conversion of SRH to homocysteine is catalyzed 
by LuxS and coupled to the production of autoinducer 
AI-2, which is a quorum sensing molecule [39, 40]. In E. 
coli and other bacteria, AI-2 has been implicated as an 
inducer of biofilm formation [41, 42] and as an attract-
ant for chemotaxis [43]. Because recycling of SAH is 
linked to the formation of AI-2, SAM regeneration is 
expected to be subject to immense regulation. A recent 
LC–MS study profiled the effect of deletions of mtn and 
luxS on intracellular concentrations of SAM, SAH, SRH, 
homocysteine, and methionine at different OD600 val-
ues for E. coli MG1655 [44]. However, overexpression of 
these genes and the possible effect on intracellular con-
centrations of the same metabolites was not tested. We 
hypothesized that overexpression of mtn and luxS may 
increase SAM availability and therefore improve vanil-
late titers.
Table 1 Summary of titers from key experiments
Rows in bold formatting are highlighted in “Discussion” section
* Titers shown for experiment 9 correspond to samples obtained 48 h after induction, which was the final sampling time. All other titers correspond to samples 
obtained 72 h after induction
Number Figure Host Genes overex‑
pressed
Methionine 
added (mM)
Protocat‑
echuate (P) 
Titer (mg/L)
Protocat‑
echuate (P) 
Titer (mM)
Vanillate (V) 
Titer (mg/L)
Vanillate (V) 
Titer (mM)
Cumulative 
P+V Titer 
(mM)
1 1B PTS-
glu + RARE’
aroG*, asbF, 
OMT
0 216 1.4 135 0.8 2.2
2 1B PTS-
glu + RARE’
aroG*, asbF, 
OMT, ppsA, 
tktA
0 308 2.0 101 0.6 2.6
3 3B PTS-
glu + RARE’
aroG*, asbF, 
OMT, ppsA, 
tktA
0 323 2.1 101 0.6 2.7
4 4D RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA
0 262 1.7 202 1.2 2.9
5 4D RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, metA, 
cysE
0 185 1.2 269 1.6 2.8
6 5B RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, sahH
0 231 1.5 168 1.0 2.5
7 5C RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, mtn, 
luxS
0 277 1.8 252 1.5 3.3
8 3B PTS-
glu + RARE’
aroG*, asbF, 
OMT, ppsA, 
tktA
10 246 1.6 168 1.0 2.6
9* 4C RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA
10 200 1.3 303 1.8 3.1
10 5D RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, sahH
10 154 1.0 269 1.6 2.6
11 5E RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, mtn, 
luxS
10 123 0.8 370 2.2 3.0
12 S3 RARE ∆metJ aroG*, asbF, 
OMT, ppsA, 
tktA, metA, 
cysE
20 139 0.9 420 2.5 3.4
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In eukaryotes, archaea, and non-LuxS-containing bac-
teria, SAM regeneration occurs differently, with conver-
sion of SAH directly to homocysteine and adenosine 
catalyzed by SAH hydrolase (SAHase) [40]. We also 
hypothesized that overexpression of a heterologous 
SAHase might provide an alternative way to improve 
protocatechuate conversion with minimal interference 
to native regulation (Fig. 5a). To explore this concept, we 
tested expression of a SAHase from S. cerevisiae (sahHSc). 
In all of the remaining experiments, neither metA* nor 
cysE* were expressed.
The two strategies intended to improve SAM regen-
eration had differing results. Final vanillate titers were 
164  ±  12  mg/L when sahHSc was expressed (Fig.  5b), 
which is lower than the 205  ±  16  mg/L previously 
observed using a relevant control plasmid expressing no 
extra genes (Fig.  4d). Few conclusions should be drawn 
about the general concept of using a SAH hydrolase from 
the worsened pathway performance observed given that 
only one variant was tested and activity was not con-
firmed. Expression of sahHSc may have introduced a met-
abolic imbalance given its dependence on NAD+, or it 
may have simply added an expression burden if the gene 
product were inactive. However, when mtn and luxS were 
overexpressed, final vanillate titers were 256 ± 11 mg/L 
(Fig.  5c). The 25  % increase in average vanillate titers 
over the no expression control suggests that overexpres-
sion of the two native genes was effective at improving 
regeneration. A significant difference was also observed 
upon supplementing cultures containing each strain with 
10 mM methionine at induction. Under these conditions, 
final vanillate titers were 274  ±  17  mg/L when sahHSc 
was expressed (Fig.  5d) and 364  ±  22  mg/L when mtn 
and luxS were overexpressed (Fig.  5e). For comparison, 
when 10 mM methionine was added to the control strain 
that did not overexpress these genes, final vanillate titers 
(at 48 h) were 299 ± 31 mg/L (Fig. 4c). Thus, overexpres-
sion of mtn and luxS improved vanillate titers in both 
the absence and presence of methionine supplementa-
tion. Table 1 contains a summary of protocatechuate and 
vanillate titers from key experiments, along with their 
cumulative titers.
Discussion
The results of this study present a detailed perspective on 
de novo vanillate biosynthesis in engineered E. coli. First, 
genetic perturbations were made upstream of the het-
erologous pathway in order to improve titers and better 
determine which reaction steps may be limiting. Upon 
identification of a limitation in the reaction catalyzed 
by OMTHs, experiments were performed that provided 
several lines of evidence that SAM availability was the 
dominant cause of the limitation. Given that conversion 
of exogenously supplied homocysteine improved vanil-
late titers, attention was next focused on deregulating 
methionine biosynthesis by targeting the global regula-
tor MetJ and the feedback-sensitive enzymes MetA and 
CysE. When deletion of metJ was coupled with expres-
sion of feedback-desensitized variants of metA* and 
cysE*, average de novo vanillate titers improved by 33 %. 
The orthogonal strategy of deregulating SAM regenera-
tion by overexpressing mtn and luxS improved average 
de novo vanillate titers by 25 %. Overall, de novo vanillate 
titers improved roughly twofold over the course of exper-
iments described in this manuscript.
In principle, the strategies of targeting biosynthesis or 
regeneration for deregulation provide different tradeoffs. 
Increasing SAM regeneration by increasing flux through 
the activated methyl cycle should be more efficient on a 
carbon basis than increasing flux through SAM biosyn-
thesis because it depletes SAH, which is a toxic molecule 
and is known to inhibit O-methyltransferases, rather 
than potentially unbalancing central metabolic precur-
sors. However, a potential disadvantage of increasing 
SAM regeneration is that the native E. coli pathway is 
coupled to biosynthesis of quorum sensing molecules 
that have widespread regulatory effects. The use of a 
yeast SAH hydrolase was motivated by the potential abil-
ity to decouple SAM regeneration and quorum sensing. 
The effectiveness of our implementation of these strate-
gies can be determined from the titers shown in Table 1. 
Although overexpression of metA* and cysE* (Table  1, 
row #5) led to slightly higher vanillate titers than over-
expression of mtn and luxS (Table 1, row #7), the latter 
strategy resulted in greater cumulative titers of proto-
catechuate and vanillate. In all cases, methionine sup-
plementation led to a greater molar ratio of vanillate to 
protocatechuate (of note are rows #11–12). These results 
suggest that further efforts towards increasing SAM 
availability would be worthwhile for improving de novo 
production.
When compared with results from previously reported 
vanillin pathway optimization studies performed in yeast, 
our observations highlight the context dependence of 
engineered metabolic pathways. Two reports published 
after the initial demonstration of the engineered yeast 
vanillin pathway describe improvements obtained using 
flux balance analysis (FBA) model-guided optimization 
[8, 9]. In the first report, OptGene was used to identify 
target reactions that, if deleted, would increase vanillin 
production. Different deletion targets were suggested 
depending on the reference flux distribution in the mini-
mization of metabolic adjustment (MOMA) biologi-
cal objective function. In general, the predicted benefit 
from these modifications was increased availability of the 
co-factors ATP and NADPH required by CarNi. Genes 
Page 11 of 17Kunjapur et al. Microb Cell Fact  (2016) 15:61 
related to pyruvate metabolism, ammonium metabo-
lism, the pentose phosphate pathway, and central carbon 
metabolism were identified. The only three modifications 
tested experimentally were deletion of one of the pyru-
vate decarboxylases (PDC1), deletion of the most active 
glutamate dehydrogenase (GDH1), and overexpression of 
GDH2 to ensure sufficient nitrogen uptake in the absence 
of GDH1. These modifications led to an overproducer 
strain that, when cultivated in a low dilution rate con-
tinuous fermentation, resulted in vanillin-β-d-glucoside 
titers of 500 mg/L [8]. As of that study, identification and 
overexpression of a potential rate-limiting enzyme in the 
pathway had not yet been described. In a second report, 
OMTHs and CarNi were overexpressed in the highest-
producing strain obtained from the previous study [9] 
based on the observed accumulation of two heterologous 
intermediates (protocatechuate and protocatechualde-
hyde). CarNi overexpression did not lead to an increase in 
production, whereas OMTHs overexpression led to a 30 % 
increase in titer (now 380  mg/L vanillin-β-d-glucoside 
compared to a different baseline than referenced above). 
However, OMTHs overexpression in the parental strain 
from the first study did not alter titer. The authors con-
cluded that this was likely because CarNi was limiting 
due to low availability of ATP and NADPH without the 
model-guided modifications made in the first study.
Given the many potential applications of methyltrans-
ferases in metabolic engineering [15, 16], the small num-
ber of reported examples in E. coli may reflect the limited 
host methylation capacity that we have encountered. In 
one report, a novel bacterial fatty acid methyltransferase 
was used to catalyze the formation of fatty acid methyl 
esters using free fatty acids and SAM [45]. The authors 
of that study note that SAM availability strongly regu-
lated methyl ester production. By deleting the metJ gene 
mentioned earlier, and by overexpressing a gene encod-
ing methionine adenosyltransferase from rat, the authors 
achieved an improvement in methyl ester production. 
However, the normalized titers of methyl esters in the 
supernatant achieved in their study increased from below 
1  µM/OD to roughly 2.5  µM/OD. The corresponding 
amount of SAM required to achieve such conversion is 
orders of magnitude below what drives production of 
hundreds of milligrams per liter of vanillate.
Other reported examples of SAM-dependent methyl-
transferase reactions engineered in E. coli include sev-
eral biotransformations to produce valuable methylated 
flavonoids, such as conversion of quercetin to rhamne-
tin [46], naringenin to 3-O-methylkaempferol [47], cou-
maric acid to 7-methoxyapigenin [48, 49], and coumaric 
acid to 7-O-methylaromadendrin [50]. Several of these 
methylated flavonoids are reported to have pharmaco-
logical properties. The largest titer reported in any of 
these examples was 111  mg/L of rhamnetin upon over-
expression of E. coli SAM synthetase (metK) [46]. Results 
obtained in this study, such as those from methio-
nine and homocysteine supplementation experiments, 
strongly suggest that conversion of methionine to SAM is 
not a primary limitation under native conditions of SAM 
biosynthesis. Rather, steps in upstream methionine bio-
synthesis and in downstream SAM regeneration appear 
to be limiting SAM utilization by heterologous methyl-
transferases, and these steps ought to receive greater ini-
tial focus for targeted deregulation. Strategies described 
in this work would likely further improve production of 
these valuable methylated flavonoids and other desired 
methylated compounds. In addition, based on the ease of 
detecting protocatechuate and vanillate, we propose that 
the vanillate pathway could serve as a convenient system 
in future studies that aim to understand and improve 
SAM biosynthesis and regeneration in E. coli.
Conclusion
In this report, we have demonstrated that the de novo 
vanillin biosynthesis pathway engineered in E. coli suffers 
from a limitation in the conversion of protocatechuate 
to vanillate. Using several experimental approaches, 
we established that limited availability of the co-sub-
strate SAM is the primary cause of the limitation. We 
then implemented two orthogonal strategies intended 
to increase SAM availability. One approach focused on 
deregulating SAM biosynthesis through metJ deletion 
and overexpression of feedback desensitized metA* and 
cysE*. The other approach aimed at deregulating SAM 
regeneration through overexpression of mtn and luxS. 
Both approaches led to increases in vanillate titer, and 
further increases were obtained through methionine sup-
plementation. These results provide useful insights for 
improving production from pathways that involve meth-
ylation in E. coli, such as the vanillin pathway.
Methods
Strains and plasmids
Escherichia coli strains and plasmids used in this study 
are listed in Table 2. Molecular biology techniques were 
performed according to standard practices [51] unless 
otherwise stated. Molecular cloning and vector propaga-
tion were performed in DH5α. All host strains used for 
production experiments were derived from E. coli K-12 
MG1655(DE3). In order to construct new host strains, 
two methods were used. The first was P1 transduction 
[52] using donor strains from the Keio collection [53] and 
P1 bacteriophage from ATCC (25404-B1). P1 transduc-
tion was used for all deletions of single genes. The sec-
ond method was recombineering using the λ Red system 
[54]. Recombineering was used to delete the yqhC-dkgA 
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operon and to upregulate galP expression by promoter 
substitution, as previously described [5]. Oligonucleo-
tides were purchased from Sigma. Q5 High Fidelity DNA 
Polymerase (New England Biolabs, MA) was used for 
DNA amplification. In all cases of host strain modifica-
tions, pCP20 was used to cure the kanamycin resistance 
cassette [54].
The aroG*, ppsA, and tktA genes were kindly provided 
by Professor Jay D. Keasling at the University of Cali-
fornia, Berkeley (USA). The genes encoding metA* and 
cysE* were synthesized as gBlocks (IDT, CA) and their 
sequences are included in Table  3. The gene encoding 
sahH from S. cerevisiae (UniProt #P39954) was codon-
optimized for expression in E. coli and also synthesized 
Table 2 Strains and plasmids used in this study
Name Relevant genotype Source
E. coli strains
 DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– 
thi-1 gyrA96 relA1
Invitrogen
 DH10B F− mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 endA1 araD139Δ(ara, leu)7697 
galU galK λ− rpsL nupG
Invitrogen
 MG1655 F− λ− ilvG- rfb-50 rph-1 ATCC 700926
 MG1655(DE3) F− λ− ilvG- rfb-50 rph-1 (DE3) Ref. [55]
 RARE MG1655(DE3) ∆dkgB ∆yeaE ∆(yqhC-dkgA) ∆yahK ∆yjgB Ref. [5]
 RARE ∆metJ MG1655(DE3) ∆dkgB ∆yeaE ∆(yqhC-dkgA) ∆yahK ∆yjgB ∆metJ This study
 PTS− glu+ MG1655(DE3) ∆ptsHIcrr Pglk::Pcon* galP
q This study, but based on Ref. [56]
 PTS− glu+ RARE’ MG1655(DE3) ∆ptsHIcrr Pglk::Pcon* galP
q ∆(yqhC-dkgA) ∆yahK ∆yjgB This study
 PTS− glu+ RARE’ ∆metJ MG1655(DE3) ∆ptsHIcrr Pglk::Pcon* galP
q ∆(yqhC-dkgA) ∆yahK ∆yjgB ∆metJ This study
E. coli plasmids
 pCP20 λ cI857 (ts), λ pr Repts, AmpR, CmR, λ pr FLP CGSC 7629
 pKD13 oriRγ, AmpR, kan CGSC 7633
 pKD46 oriR101, repA101ts, AmpR, araC, araBp-λγ-λβ-λexo CGSC 7739
 pETDuet-1 AmpR, lacI, T7lac Novagen
 pACYCDuet-1 CmR, lacI, T7lac Novagen
 pCOLADuet-1 KanR, lacI, T7lac Novagen
 pCDFDuet-1 StrR, lacI, T7lac Novagen
 pACYC-car-sfp pACYCDuet-1 harboring caropt (carboxylic acid reductase from Nocardia iowensis, codon-
optimized for expression in E. coli) and sfpopt (phosphopantetheinyl transferase from 
Bacillus subtilis, codon optimized for expression in E. coli)
Ref. [5]
 pET-OMT-asbF pETDuet-1 harboring Hs-S-COMTopt (catechol O-methyltransferase from Homo sapiens, 
codon-optimized for expression in E. coli) and asbFopt (dehydroshikimate dehydratase 
from Bacillus thuringiensis, codon optimized for expression in E. coli)
Ref. [5]
 pS4 Plasmid containing the shikimate module, version 4, kindly provided by the Keasling Lab 
at UC Berkeley. (Source of aroG*-ppsA-tktA artificial operon)
Ref. [57]
 pACYC-aroG* pACYCDuet-1 harboring the feedback-resistant aroG* from E. coli This study
 pACYC-aroG*-ppsA-
tktA
pACYCDuet-1 harboring three E. coli genes in an artificial operon: aroG*, ppsA, and tktA This study
 pCOLA-metK pCOLADuet-1 harboring the E. coli metK gene This study
 pET-OMT pETDuet-1 harboring Hs-S-COMTopt This study
 pCOLA-metA* pCOLADuet-1 harboring a feedback-desensitized version of E. coli metA (27_Arg- > Cys, 
296_Ile- > Ser, and 298_Pro- > Leu, “metA*”)
This study
 pCOLA-cysE* pCOLADuet-1 harboring a feedback-desensitized version of E. coli cysE (95_Val- > Arg, and 
96_Asp- > Pro, “cysE*”)
This study
 pCOLA-metA*-cysE* pCOLADuet-1 harboring an artificial operon consisting of the metA* and cysE* genes This study
 pCDF-car-sfp pCDFDuet-1 harboring an artificial operon containing caropt and sfpopt This study
 pCOLA-mtn pCOLADuet-1 harboring the E. coli mtn gene This study
 pCOLA-mtn-luxS pCOLADuet-1 harboring an artificial operon consisting of the E. coli mtn and luxS genes This study
 pCOLA-sahH pCOLADuet-1 harboring sahHSc (S-adenosylhomocysteine hydrolase from S. cerevisiae, 
codon-optimized for expression in E. coli)
This study
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as a gBlock (Table  3). The E. coli metK, mtn, and luxS 
genes were amplified from MG1655(DE3) genomic DNA 
using PCR amplication and the oligonucleotides shown 
in Table 4. All genes of interest were cloned into the Duet 
vector system (Novagen, WI) using restriction digest-
based cloning. Restriction enzymes used to clone each 
gene are either shown in Table 3 (if the gene was synthe-
sized) or in Table 4 (if the gene was amplified). Restric-
tion enzymes and T4 DNA ligase were purchased from 
New England Biolabs. Propagated constructs were puri-
fied using a QIAprep Miniprep Kit (Qiagen, CA) and aga-
rose gel fragments were purified using a Zymoclean Gel 
DNA Recovery Kit (Zymo Research, CA). All constructs 
were confirmed to be correct by nucleotide sequencing 
(Genewiz, NJ).
Chemicals
The following compounds were purchased from Sigma: 
vanillic acid, protocatechuic acid (otherwise known as 
3,4-dihydroxybenzoic acid), l-methionine, l-homo-
cysteine, l-cysteine, and l-aspartate. Isopropyl β-d-
1-thiogalactopyranoside (IPTG) was purchased from 
Denville Scientific. Ampicillin sodium salt, chloramphen-
icol, streptomycin sulfate, and kanamycin sulfate were 
purchased from Affymetrix.
Culture conditions
A 1X M9 salt medium (Sigma) containing 6.78  g/L 
Na2HPO4∙7H2O, 3  g/L KH2PO4, 1  g/L NH4CI, and 
0.5 g/L NaCl, supplemented with 2 mM MgSO4, 0.1 mM 
CaCl2, glucose, trace elements, and antibiotics was used 
Table 3 Synthesized gene sequences used in this study
Gene (and restriction enzymes) DNA sequence. Restriction enzyme sites are underlined and start/stop codons are in bold
metA* (NdeI/AatII) AAAAAACATATGCCGATTCGTGTGCCGGACGAGCTACCCGCCGTCAATTTCTTGCGTGAAGAAAACGTCTTTGTGA 
TGACAACTTCTTGTGCGTCTGGTCAGGAAATTCGTCCACTTAAGGTTCTGATCCTTAACCTGATGCCGAAGAAGAT 
TGAAACTGAAAATCAGTTTCTGCGCCTGCTTTCAAACTCACCTTTGCAGGTCGATATTCAGCTGTTGCGCATCGATTC 
CCGTGAATCGCGCAACACGCCCGCAGAGCATCTGAACAACTTCTACTGTAACTTTGAAGATATTCAGGATCAGAACTT 
TGACGGTTTGATTGTAACTGGTGCGCCGCTGGGCCTGGTGGAGTTTAATGATGTCGCTTACTGGCCGCAGATCAAACA 
GGTGCTGGAGTGGTCGAAAGATCACGTCACCTCGACGCTGTTTGTCTGCTGGGCGGTACAGGCCGCGCTCAATATCC 
TCTACGGCATTCCTAAGCAAACTCGCACCGAAAAACTCTCTGGCGTTTACGAGCATCATATTCTCCATCCTCATGCGC 
TTCTGACGCGTGGCTTTGATGATTCATTCCTGGCACCGCATTCGCGCTATGCTGACTTTCCGGCAGCGTTGATTCGTGA 
TTACACCGATCTGGAAATTCTGGCAGAGACGGAAGAAGGGGATGCATATCTGTTTGCCAGTAAAGATAAGCGCATTG 
CCTTTGTGACGGGCCATCCCGAATATGATGCGCAAACGCTGGCGCAGGAATTTTTCCGCGATGTGGAAGCCGGACTA 
GACCCGGATGTACCGTATAACTATTTCCCGCACAATGATCCGCAAAATACACCGCGAGCGAGCTGGCGTAGTCACGG-
TAATTTACTGTTTACCAACTGGCTCAACTATTACGTCTACCAGAGCACGCTATACGATCTACGGCACATGAATCCAACG 
CTGGATTAAGACGTCAAAAAA
cysE* (AatII/XhoI) AAAAAAGACGTCTAATAAAAGGAGATATACCATGTCGTGTGAAGAACTGGAAATTGTCTGGAACAATATTAAAGCCGAAG 
CCAGAACGCTGGCGGACTGTGAGCCAATGCTGGCCAGTTTTTACCACGCGACGCTACTCAAGCACGAAAACCTTGGC 
AGTGCACTGAGCTACATGCTGGCGAACAAGCTGTCATCGCCAATTATGCCTGCTATTGCTATCCGTGAAGTGGTGGAAG 
AAGCCTACGCCGCTGACCCGGAAATGATCGCCTCTGCGGCCTGTGATATTCAGGCGGTGCGTACCCGCGACCCGGCA 
AGACCCAAATACTCAACCCCGTTGTTATACCTGAAGGGTTTTCATGCCTTGCAGGCCTATCGCATCGGTCACTGGTTGTGG 
AATCAGGGGCGTCGCGCACTGGCAATCTTTCTGCAAAACCAGGTTTCTGTGACGTTCCAGGTCGATATTCACCCGGCA 
GCAAAAATTGGTCGCGGTATCATGCTTGACCACGCGACAGGCATCGTCGTTGGTGAAACGGCGGTGATTGAAAACGAC 
GTATCGATTCTGCAATCTGTGACGCTTGGCGGTACGGGTAAATCTGGTGGTGACCGTCACCCGAAAATTCGTGAAGGTG 
TGATGATTGGCGCGGGCGCGAAAATCCTCGGCAATATTGAAGTTGGGCGCGGCGCGAAGATTGGCGCAGGTTCCGTGG 
TGCTGCAACCGGTGCCGCCGCATACCACCGCCGCTGGCGTTCCGGCTCGTATTGTCGGTAAACCAGACAGCGATAAG 
CCATCAATGGATATGGACCAGCATTTCAACGGTATTAACCATACATTTGAGTATGGGGATGGGATCTAACTCGAGAAAAAA
sahHSc (NcoI/NotI) ATATATCCATGGGCGCCCCTGCTCAGAATTATAAAATTGCAGATATCTCACTGGCAGCGTTCGGTCGTAAGGAAATTGAATT 
GGCAGAGCACGAAATGCCAGGCCTGATGGCAATTCGTAAAGCCTATGGCGACGTTCAACCGCTGAAGGGCGCACGTA 
TCGCGGGTTGCTTACACATGACGATCCAAACCGCCGTGCTGATTGAGACATTAGTCGCTTTGGGAGCCGAGGTTACGT 
GGTCGTCATGCAATATCTACTCGACGCAAGATCATGCGGCAGCGGCAATCGCTGCAAGCGGCGTGCCTGTGTTTGCTTGG 
AAAGGTGAAACCGAAGAGGAATACCTGTGGTGCATTGAACAGCAGCTGTTTGCATTCAAGGATAACAAAAAATTGAACC 
TGATTTTGGACGACGGCGGGGATTTAACAACCTTAGTTCACGAGAAACATCCTGAAATGCTGGAGGATTGTTTTGGCCT 
TTCCGAAGAAACCACCACCGGTGTCCACCACCTCTACCGCATGGTTAAAGAGGGTAAACTTAAAGTCCCGGCTATCAATG 
TGAACGACTCAGTAACCAAATCCAAATTTGATAACTTATATGGTTGCCGTGAAAGCCTGGTTGACGGGATTAAGCGCGCC 
ACGGATGTTATGCTTGCCGGAAAGGTGGCTGTTGTGGCCGGTTACGGTGACGTGGGTAAAGGATGCGCAGCCGCGTT 
ACGTGGCATGGGTGCACGCGTGTTAGTTACGGAAATTGATCCTATCAATGCCCTGCAGGCCGCGATGGAAGGCTATCAAG 
TGGTAACAATGGAAGATGCCTCACATATCGGTCAGGTGTTCGTTACGACCACGGGTTGTCGTGATATCATCAACGGGGAGC| 
ATTTCATTAACATGCCGGAAGATGCAATTGTTTGTAACATCGGGCATTTCGATATTGAGATCGACGTGGCGTGGCTCAAAG 
CCAATGCCAAAGAGTGTATTAACATTAAACCGCAGGTAGATCGTTATTTGCTGAGCTCTGGCCGTCATGTCATCCTCCTGG 
CAAATGGACGCCTTGTGAATCTGGGTTGTGCGACGGGTCACTCGTCCTTCGTCATGAGCTGCTCTTTTTCCAACCAGG 
TTCTGGCACAAATCGCCCTGTTTAAATCTAATGACAAATCTTTTCGCGAAAAACACATCGAGTTCCAGAAGACCGGTCCC 
TTCGAAGTCGGGGTTCATGTGTTGCCTAAAATCTTAGATGAGGCAGTCGCTAAATTTCATCTTGGCAACCTGGGTGTCC 
GTCTGACCAAACTGAGTAAAGTCCAGAGCGAGTACCTGGGTATTCCGGAGGAAGGACCTTTCAAAGCGGATCATTATC 
GCTATTAAGCGGCCGCAAATTT
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as the culture medium for experiments in this study. 
The trace element solution (100×) used contained 
5  g/L EDTA, 0.83  g/L FeCl3∙6H2O, 84  mg/L ZnCl2, 
10  mg/L CoCl2∙6H2O, 13  mg/L CuCI2∙2H2O, 1.6  mg/L 
MnCl2∙2H2O and 10 mg/L H3BO3 dissolved in water. This 
was added to a concentration of 1× to supplement the 
M9-glucose medium. This medium will be henceforth 
referred to as “M9-glu-trace.” For all experiments except 
the experiment corresponding to Fig. 1b, the initial glu-
cose concentration was 1.8 %. The initial glucose concen-
tration was 1.2  % for the experiment corresponding to 
Fig. 1b.
All experiments were performed in 250  ml baffled 
PYREX shake flasks that contained 50  ml culture vol-
umes. Overnight cultures were grown in 3  ml in 14  ml 
round-bottom tubes (Corning). Experimental cultures 
were initiated as follows: 1 % (v/v) inoculum volumes of 
overnight culture in LB medium were first transferred 
into overnight culture in M9-glu-trace medium, and 
then 1 % (v/v) inoculum volumes of overnight culture in 
M9-glu-trace were transferred into 50 mL M9-glu-trace 
medium, incubated at 30  °C, and agitated at 250  rpm. 
The OD600 was measured regularly during exponen-
tial growth using a DU800 UV/Vis spectrophotometer 
(Beckman Coulter). Cultures were induced with 0.5 mM 
IPTG at OD600 values between 0.8 and 1.0. Depending 
on the experiment, culture medium was supplemented 
with either 50  mg/L ampicillin, 17  mg/L chlorampheni-
col, 25 mg/L streptomycin, 25 mg/L kanamycin, or com-
binations of the previous antibiotics to provide selective 
pressure for plasmid maintenance. In some experiments 
(Figs.  4, 5; Additional file  1: Figures S2–S4), 50  mg/L 
carbenicillin was used in place of ampicillin in liquid 
cultures to provide more stringent pressure for plasmid 
maintenance. All experiments were performed in biologi-
cal triplicate, and results are presented as averages with 
error bars representing one standard deviation.
For experiments in which S-adenosyl-l-methionine 
precursors were supplemented, flask cultures were set up 
as mentioned before but with culture volumes adjusted to 
achieve final concentrations as follows: 10 mM l-methio-
nine, 2.5  mM l-homocysteine, 10  mM l-cysteine, or 
10 mM l-aspartate. Stocks of supplemented metabolites 
were pH-neutralized and sterile filtered. In these experi-
ments, control cultures received an equal volume of ster-
ile deionized water instead of the metabolic precursors 
at the time of supplementation. Supplementation times 
varied from occurring at induction (0 h), occurring 24 h 
after induction, and occurring at both induction and 24 h 
after induction.
Metabolite analysis
Culture samples were pelleted by centrifugation and 
aqueous supernatant was collected for HPLC analysis 
using an Agilent 1100 series instrument equipped with a 
diode array detector. Heterologous compounds produced 
in vanillin experiments were separated using a Zorbax 
Eclipse XDB-C18 column (Agilent) and detected using a 
wavelength of 280 nm. A gradient method used the fol-
lowing solvents: (A) 50  % acetonitrile+ 0.1  % trifluoro-
acetic acid (TFA); (B) water+ 0.1  % TFA. The gradient 
began with 5 % Solvent A and 95 % Solvent B. The setting 
at 20 min was 60 % Solvent A and 40 % Solvent B. The 
program restored the original ratio at 22 min and ended 
Table 4 Oligonucleotides used in this study
Name Sequence (5′– >3′)
MetJ-verify-f TCTTTAGCAATCACCACG
MetJ-verify-r GGAATATTCTTGCCGTAAC
PtsHICrr-verify-f GAAAGGCGCAATCCAA
PtsHICrr-verify-r CGATTTGACTGCCAGAAT
AroG*-f (BglII) AAAAAAAGATCTGATGAATTATCAGAACGACGATTTAC
AroG*-r (AvrII) AAAAAACCTAGGCCTCCTTTAGATCCTTACCC
AroG*-PpsA-TktA-f (BglII) AAAAAAAGATCTGATGAATTATCAGAACGACGATTTAC
AroG*-PpsA-TktA-r (AvrII) AAAAAACCTAGGTTACAGCAGTTCTTTTGCTTTC
MetK-f (NdeI) AAAAAACATATGGCAAAACACCTTTTTAC
MetK-r (AvrII) AAAAAACCTAGGTTACTTCAGACCGGCAG
Mtn-f (NcoI) AAAAAACCATGGGCAAAATCGGCATCATTGG
Mtn-r (NotI) AAAAAAGCGGCCGCTTAGCCATGTGCAAGTTTCT
LuxS-f (NotI) AAAAAAGCGGCCGCTAATAAAGGAGATATACCATGCCGTTGTTAGATAGCTT
LuxS-r (AflII) AAAAAACTTAAGCTAGATGTGCAGTTCCTGC
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at 25 min. The flow rate was 1.0 ml/min and all vanillin 
pathway compounds of interest eluted within 15  min. 
Column temperature was maintained at 30 °C.
SDS–PAGE analysis
To determine qualitative protein expression level of 
OMT in the absence of other pathway gene overexpres-
sion, E. coli MG1655(DE3) was transformed with empty 
pETDuet-1 or pET-OMT. Single colonies from plates of 
each transformation were grown overnight in 3 ml of LB 
with 50  mg/L ampicillin. Cells were passaged into sec-
ond overnight cultures by inoculating 3 ml of M9+ 1.8 % 
glucose with 100 μL of the overnight LB cultures. Shake 
flask cultures containing 50 ml M9+ 1.8 % glucose were 
inoculated at 1 % inoculum from overnight M9 cultures 
and incubated with agitation at 30 °C and 250 rpm. Cul-
tures were induced with 0.5  mM IPTG at OD600 values 
between 0.8 and 1.0. Twenty-four hours after induc-
tion, 5 ml of each culture were sampled and pelleted by 
centrifugation. Cell pellets were resuspended in 1  ml 
of 10  mM Tris–HCl at pH 8.0 and lysed using sonica-
tion. After lysis, samples were pelleted by centrifugation 
(16,000g, 4 °C, 20 min) and supernatant was collected as 
soluble lysate. The remaining pellet was resuspended in 
10 mM Tris–HCl and deemed the insoluble fraction.
Total protein was quantified by the Bradford assay 
method [58] using Bio-Rad Protein Assay Dye Rea-
gent (Cat #500-0006) and a bovine serum album (BSA) 
standard. A Bio-Rad 10 % Mini-PROTEAN TGX gel (Cat 
#456-1034) was run using the Mini-PROTEAN Tetra 
Cell electrophoresis apparatus. Bio-Rad Precision Plus 
Protein All Blue Standard (Cat #161-0373) and 10 μg of 
total protein for each sample was loaded on the gel. After 
running at 200 volts for 33 min, the gel was washed with 
deionized water before staining with Bio-Rad Bio-Safe 
Coomassie Stain (Cat #161-0786).
O‑methyltransferase in vitro specific activity
To determine the specific activity of the O-methyltrans-
ferase as a function of time in the context of the pathway, 
E. coli MG1655(DE3) was transformed with pET-OMT-
AsbF and pACYC-AroG*-PpsA-TktA plasmids. Sin-
gle colonies from plates of each transformation were 
grown overnight in 3 ml of LB with 50 mg/L ampicillin 
and 17 mg/L chloramphenicol. Cells were passaged into 
second overnight cultures by inoculating 3  ml of M9+ 
1.8 % glucose+ antibiotics with 100 μL of the overnight 
LB cultures. Shake flask cultures containing 50 ml M9+ 
1.8 % glucose+ antibiotics were inoculated at 1 % inoc-
ulum from overnight M9 cultures and incubated with 
agitation at 30  °C and 250  rpm. Cultures were induced 
with 0.5 mM IPTG at OD600 values between 0.8 and 1.0. 
At 12  h time point increments after induction, 5  ml of 
each culture were sampled and pelleted by centrifuga-
tion. Cell pellets were resuspended in 1  ml of 100  mM 
sodium phosphate buffer at pH 7.5 and lysed using soni-
cation. After lysis, samples were pelleted by centrifuga-
tion (16,000g, 4  °C, 20 min) and supernatant containing 
OMT was collected.
The OMT activity assay contained the following final 
concentrations to a final volume of 600  µL per sam-
ple: 100 mM sodium phosphate buffer (pH 7.5), 2 mM 
protocatechuate, 2  mM S-adenosylmethionine, 5  mM 
MgCl2, and roughly 0.1  mg/mL BSA protein equiva-
lent of lysate (60  µL). Lysate was always added last, 
and immediately upon addition, the assay solution was 
split into two 300 µL volumes (ti and tf). The ti volume 
was quenched with 1  % TFA, and the tf was quenched 
in the same manner after 1  h. Both volumes for each 
sample were maintained at 30  °C. Potential debris 
from quenched volumes were pelleted by centrifuga-
tion (16,000g, 4  °C, 3  min) and supernatant was ana-
lyzed by HPLC. Concentrations of protocatechuate and 
vanillate were measured as described before. Specific 
OMT activity was calculated by dividing differences in 
vanillate concentration by total protein concentration 
in corresponding lysate. Specific activities were subse-
quently normalized to the activity at the first time point 
sampled (12  h). Lysate from a strain transformed with 
empty pET was used as a control in otherwise identical 
assays to ensure there was no background conversion of 
protocatechuate.
Calculation of maximum theoretical pathway yield
Maximum theoretical yields presented for vanillin and 
vanillate were calculated using an in silico genome-
scale metabolic model of E. coli (iJO1366) [59] and the 
constraint-based reconstruction and analysis (COBRA) 
toolbox version 2.0 [60, 61] within the framework of 
MATLAB 2013a. Heterologous vanillin pathway reac-
tions were added to the model, and uptake rates for 
glucose and oxygen were set to −10  mmol/gDW-h and 
−1000 mmol/gDW-h, respectively [62].
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